Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
5
×
life sciences
national blog main
san diego blog main
san diego top stories
5
×
boston blog main
clinical trials
san francisco blog main
san francisco top stories
biotech
boston top stories
national top stories
new york blog main
new york top stories
alnylam pharmaceuticals
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
rna interference
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
3d imaging
akcea therapeutics
ambys medicines
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
arena pharmaceuticals
athenex
What
patients
5
×
fda
drug
developers
medicine
therapy
time
add
ago
alnylam
approve
aren’t
awaits
bio
biological
called
cancer
carbidopa
combination
control
crossed
daily
daunting
decades
decision
discovered
disease
drugs
eisai
experience
fingers
firms
flags
friday
gene
gets
healthcare
help
higher
historic
Language
unset
Current search:
fda
×
" san diego top stories "
×
patients
×
@xconomy.com
4 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets